Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Chemical analysis
Reexamination Certificate
2005-09-06
2005-09-06
Allen, Marianne P. (Department: 1631)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Chemical analysis
C702S019000, C702S020000, C435S007200
Reexamination Certificate
active
06941229
ABSTRACT:
The present invention relates to a method of designing compounds able to bind to a molecule of the EGF receptor family and to modulate the activity mediated by the receptor molecule based on the 3-D structure coordinates of the EGF receptor crystal ofFIG. 6.
REFERENCES:
patent: 5705335 (1998-01-01), Hendry
patent: 5708156 (1998-01-01), Ilekis
patent: 94/25860 (1994-11-01), None
Kuntz et al. “A Geometric Approach to Macromolecule-Ligand Interactions”. J. Mol. Biol. (1982), vol. 161, pp. 269-288.
Goodford, P.J. “A Computational Procedure for Determining Energetically Favorable Binding Sites on Biologically Important Macromolecules”, J. Med. Chem. (1985), vol. 28, pp. 8489-8857.
“Disulfide Bond Structure of Human Epidermal Growth Factor Receptor” by Abe et al., The Journal of Biological Chemistry, vol. 273, No. 18, May 1, 1998, pp. 11150-11157.
“Modelling the ATP-Binding Site of Oncogene Products, the Epidermal Growth Factor Receptor and Related Proteins” by Sternberg et al., FEBS, vol. 175, No. 2, Oct. 1984, pp. 387-392.
“Design of a Potent Peptide Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase Utilizing Sequences Based on the Natural Phosphorylation Sites of Phospholipase C-γ1” by Fry et al., pp. 951-957.
“Crystal Structure of the First Three Domains of the Type-1 Insulin-Like Growth Factor Receptor” by Garrett et al., Nature, vol. 394, Jul. 23, 1998, pp. 395-399.
Singh, Juswinder., et al. “Structure-Based Design of a Patent, Selective and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases,” Journal of Medicinal Chemistry, American Chemical Society, vol. 40, Mar. 28, 1997, pp. 1130-1135, XP002107337.
Garrett. Thomas P., et al. “Crystal structure of the first three domains of the type-1 Insulin-like growth factor receptor,” Nature (London) vol. 394, No. 6691, Jul. 23, 1998, pp. 395-399, XP002297751.
McInnes, Cambell., et al. “NMR study of the transforming growth factor-alpha (TGF-alpha)-epidermal growth factor receptor complex. Visualization of human TGF-alpha binding determinants through nuclear Overhauser enhancement analysis.” Journal of Biological Chemistry, vol. 271, No. 50, 1996, pp. 32204-32211, XP002297752.
Sanchez, Roberto., et al. “Evaluation of Comparative Protein Structure Modeling by MODDELLER-3” Proteins, Structure, Function and Genetics, Suppl. Pp. 1:50-58 (1997.
Burgess Antony Wilks
Elleman Thomas Charles
Epa Vidanagamage Chandana
Garrett Thomas Peter John
Jorissen Robert Nicholas
Allen Marianne P.
Commonwealth Scientific and Industrial Research Organization
Ludwig Institute for Cancer Research
McDermott Will & Emery LLP
LandOfFree
Method of designing agonists and antagonists to EGF receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of designing agonists and antagonists to EGF receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of designing agonists and antagonists to EGF receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3442769